1. Home
  2. ELUT vs NNVC Comparison

ELUT vs NNVC Comparison

Compare ELUT & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$0.59

Market Cap

23.3M

Sector

Health Care

ML Signal

HOLD

NNVC

NanoViricides Inc.

HOLD

Current Price

$1.10

Market Cap

26.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELUT
NNVC
Founded
2015
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.3M
26.7M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ELUT
NNVC
Price
$0.59
$1.10
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
502.1K
341.7K
Earning Date
11-06-2025
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$21,746,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
24.08
N/A
52 Week Low
$0.50
$0.94
52 Week High
$3.99
$2.23

Technical Indicators

Market Signals
Indicator
ELUT
NNVC
Relative Strength Index (RSI) 43.34 37.52
Support Level $0.52 $1.20
Resistance Level $0.59 $1.31
Average True Range (ATR) 0.06 0.08
MACD 0.00 -0.01
Stochastic Oscillator 39.34 0.00

Price Performance

Historical Comparison
ELUT
NNVC

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About NNVC NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

Share on Social Networks: